Shopping Cart
- Remove All
- Your shopping cart is currently empty
MY-1B is a nitrogen-containing substituted butenamide stereoprobe, capable of blocking stereoselective enrichment of NSUN2, specifically binding to NSUN2 at C271.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $136 | In Stock | |
5 mg | $338 | In Stock | |
10 mg | $538 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,490 | In Stock | |
100 mg | $1,980 | In Stock | |
200 mg | $2,670 | In Stock |
Description | MY-1B is a nitrogen-containing substituted butenamide stereoprobe, capable of blocking stereoselective enrichment of NSUN2, specifically binding to NSUN2 at C271. |
Targets&IC50 | NSUN2:1.3 μM |
In vitro | Methods: The binding of NSUN2_C271 was observed in the human prostate cancer cell line 22Rv1 treated with 5 or 20 μM MY-1B (3 hours). Results: Almost complete binding of NSUN2_C271 (>90%) was observed in the human prostate cancer cell line 22Rv1. [1] The Kinact/Ki value of MY-1B (2.5-20 µM) against recombinant NSUN2 methyltransferase activity at different pre-incubation times and concentrations was 67±15 M. [1] |
Alias | MY1B |
Molecular Weight | 436.3 |
Formula | C22H18BrN3O2 |
Cas No. | 2929308-79-0 |
Smiles | C(NC=1C2=C(C=CC1)C=CC=N2)(=O)[C@H]3[C@H](CN3C(C=C)=O)C4=CC=C(Br)C=C4 |
Relative Density. | no data available |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80.00 mg/mL (183.36 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.